Article info

Download PDFPDF
Efficiency of tofacitinib in refractory interstitial lung disease among anti-MDA5 positive juvenile dermatomyositis patients

Authors

  • Yuan Xue Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Junmei Zhang Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China Department of Nephrology and Rheumatology, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China Department of Nephrology and Rheumatology, Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou, China PubMed articlesGoogle scholar articles
  • Jianghong Deng Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Weiying Kuang Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Jiang Wang Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Xiaohua Tan Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Chao Li Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Shipeng Li Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  • Caifeng Li Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Caifeng Li, Department of Rheumatology, Beijing Children's Hospital, Capital Medical University, National Centre for Children’s Health, Beijing, 100045, China; caifeng_li{at}yeah.net
View Full Text

Citation

Xue Y, Zhang J, Deng J, et al
Efficiency of tofacitinib in refractory interstitial lung disease among anti-MDA5 positive juvenile dermatomyositis patients

Publication history

  • Received January 19, 2023
  • Accepted May 15, 2023
  • First published June 6, 2023.
Online issue publication 
November 01, 2023

Article Versions